Airbus hits record highs, 737 MAX buyers fall on latest Boeing news
Airbus’ shares hit record highs on Wednesday, after U.S. arch rival Boeing warned of further delay in returning its grounded 737 MAX airliner to service, while Boeing customers and suppliers fell on the news.
Oil falls as surplus forecast overshadows Libya disruption
Oil prices fell on Wednesday as a market surplus forecast by the International Energy Agency (IEA) outweighed concern over disruptions to Libya’s crude output.
Exclusive: Eurazeo hires banks for $2.2 billion sale of payments firm Planet – sources
European buyout fund Eurazeo has hired Citigroup and Evercore to prepare the sale of its payments business Planet in a deal that could value the Irish firm at up to 2 billion euros ($2.22 billion), three sources told Reuters.
J&J forecasts weak annual profit, misses revenue estimates
Johnson & Johnson on Wednesday forecast 2020 profit below Wall Street estimates and said increased competition for its off-patent treatments could somewhat limit growth in the top-earning pharmaceuticals unit.
Daimler profits halve on diesel and restructuring charges
Daimler warned its earnings halved in 2019 and it faced further charges of up to 1.5 billion euros ($1.7 billion)related to diesel pollution, in the latest blow to the German luxury carmaker.
Diabetes, heart device sales fuel Abbott’s revenue beat
Abbott Laboratories Inc beat quarterly sales estimates on Wednesday, boosted by higher revenue from its diabetes and heart devices.
S&P 500 aims for record open on IBM support, fading China virus fears
U.S. stock index futures pointed to fresh highs for the S&P 500 on Wednesday, as investors took heart from China’s efforts to contain a deadly virus outbreak, while strong results from IBM and Netflix boosted earnings optimism.
Insurers look to curb ransomware exposure as U.S. cyber rates rise
U.S. insurers are ramping up cyber-insurance rates by as much as 25% and trying to curb exposure to vulnerable customers after a surge of costly claims, industry sources said.
With record profits on Wall Street, small bonuses will annoy bankers: experts
Most Wall Street banks announced their fourth quarter profits beat industry expectations last week. But by the end of this week, bank sources and compensation experts told Reuters, most of their staff will be underwhelmed by their bonuses.
J&J misses revenue estimates as blockbuster drugs disappoint
Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer drug Imbruvica fell short of expectations.
